tiprankstipranks
The Fly

Axsome Therapeutics price target raised to $153 from $133 at Needham

Axsome Therapeutics price target raised to $153 from $133 at Needham

Needham raised the firm’s price target on Axsome Therapeutics (AXSM) to $153 from $133 and keeps a Buy rating on the shares. The company’s Q4 results were “uneventful” following its pre-announcement earlier last month, though the weakness in the stock is a reflection of the recent move following the Auvelity IP settlement and low investor expectations ahead of the Q1 Phase 3 data readouts for solriamfetol in ADHD and MDD – major depressive disorder – the analyst tells investors in a research note.

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1